UMDNJ
Having recently secured funding from a private investor, moved to the San Francisco Bay Area, and obtained the rights to a key patent covering its core nucleic acid probe technology, molecular diagnostics startup QuanDx is now shifting its attention toward developing clinical ass
Biosearch Licenses Stellaris RNA FISH-based Technology from UMDNJ
NEW YORK (GenomeWeb News) – Biosearch Technologies today said that it has acquired the exclusive worldwide rights to continuing Stellaris RNA FISH-based inventions from the University of Medicine and Dentistry of New Jersey.
Thermo Fisher Scientific has been awarded US Patent No. 8,378,115, "Monomethine dyes."
Charles Brush, Jianqin Liu, Peter Czerney, and Matthias Wenzel are named as inventors.
UMDNJ Group Develops 'Super' Selective Primer Tech for Low-Level qPCR-Based Mutation Detection
Premium
SAN FRANCISCO — Researchers from the University of Medicine and Dentistry of New Jersey and New Jersey Medical School this week unveiled a new qPCR-based mutation-detection chemistry at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference held here.
At NGS-Heavy AMP Meeting, Clinical Researchers Still Get Behind PCR for Infectious Disease Dx
Premium
The Association for Molecular Pathology's annual meeting, held last week in Long Beach, Calif., focused strongly on next-generation sequencing and its implementation in the clinic, especially for diagnosing, monitoring, and tailoring treatments for cancer.
Mar 9, 2012
Mar 1, 2012
Aug 23, 2011
Sep 2, 2010